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PredictionExtensive research efforts have been directed toward strategies for predicting risk of developing Alzheimer's
disease (AD) prior to the appearance of observable symptoms. Existing approaches for early detection of AD
vary in terms of their efﬁcacy, invasiveness, and ease of implementation. Several non-invasive magnetic res-
onance imaging strategies have been developed for predicting decline in cognitively healthy older adults.
This review will survey a number of studies, beginning with the development of a famous name discrimina-
tion task used to identify neural regions that participate in semantic memory retrieval and to test predictions
of several key theories of the role of the hippocampus in memory. This task has revealed medial temporal and
neocortical contributions to recent and remote memory retrieval, and it has been used to demonstrate com-
pensatory neural recruitment in older adults, apolipoprotein E ε4 carriers, and amnestic mild cognitive im-
pairment patients. Recently, we have also found that the famous name discrimination task provides predictive
value for forecasting episodic memory decline among asymptomatic older adults. Other studies investigating
the predictive value of semantic memory tasks will also be presented. We suggest several advantages
associated with the use of semantic processing tasks, particularly those based on person identiﬁcation, in com-
parison to episodic memory tasks to study AD risk. Future directions for research and potential clinical uses of
semantic memory paradigms are also discussed. This article is part of a Special Issue entitled: Imaging Brain
Aging and Neurodegenerative disease.Brain Aging and Neurodegen-
st.
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1.1. Alzheimer's disease and prediction
Alzheimer's disease (AD) is a worldwide health concern. It has
been projected that by the year 2050, over 100 million people world-
wide will be diagnosed with AD [1], including between 8 and 13 mil-
lion individuals in the United States [2]. Currently, there are no
effective treatments for persons with AD. However, several promising
strategies have been identiﬁed that may delay or even prevent theprogression of AD [3]. Various lifestyle factors, such as dietary modi-
ﬁcations [4] and participation in physical [5], social [6,7], and cogni-
tively stimulating activities [8,9], have been associated with a
decreased risk for developing AD. It is known that AD-related neuro-
pathology begins to accumulate decades prior to the onset of cogni-
tive symptoms [10,11]. Thus, implementation of an intervention
well before the onset of observable symptoms, such as episodic mem-
ory loss, could provide the greatest opportunity to slow or minimize
damage due to the disease, particularly if they are targeted toward in-
dividuals with the greatest risk of developing AD.
In order to identify those individuals who are at the highest likeli-
hood of developing the disease, considerable research efforts have been
directed toward identifying speciﬁc risk factors and biomarkers of the
disease. Two well-established risk factors for late-onset, non-sporadic
AD are a history of dementia in aﬁrst-degree relative [12] and possession
of one or more apolipoprotein (APOE) ε4 alleles [13–15]. However,
these factors alone are far from perfect in predicting who will develop
the disease, andanumber of studies have recently started to identify pre-
clinical biomarkers [16]. Cerebrospinal ﬂuid (CSF) indices of isoprostane
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(Aβ42) [17,23–25] levels have been successful in predicting conversion
from mild cognitive impairment (MCI) to AD. Additionally, neuroimag-
ing methods have been used to predict conversion from MCI to AD, in-
cluding structural magnetic resonance imaging (sMRI) of hippocampal
volume [26–28], hippocampal rate of atrophy [29–31], and entorhinal
cortex [31–34] volume, electroencephalography (EEG) [35,36], and
positron emission tomography (PET) using measurement of regional
glucose metabolism [37–39] and amyloid imaging [40–42].
While a number of studies have been successful in predicting con-
version from MCI to AD, predicting cognitive decline or onset of de-
mentia in cognitively healthy older adults presents a greater
challenge. Longitudinal follow-up intervals need to be conducted
over a sufﬁciently long time frame to observe a clinically signiﬁcant
amount of cognitive decline. Because participants are by deﬁnition
cognitively intact, determination of whether performance changes
over time is a reﬂection of test unreliability, practice effects, or age-
appropriate cognitive change can be difﬁcult. Furthermore, clinical
samples need to be large in order to detect an adequate number of
participants who actually do show cognitive decline. Given the ex-
pense of neuroimaging methods, it is often difﬁcult to dedicate the re-
sources necessary to studies of this magnitude. Hence, most
longitudinal neuroimaging studies to date have attempted to predict
conversion of MCI to AD. However, for interventions to be maximally
effective in altering the disease course of AD, earlier identiﬁcation of
AD risk is essential. Advanced neuroimaging methodologies have
considerable potential to function as biomarkers of risk. Therefore,
longitudinal neuroimaging studies focusing on prediction of cognitive
decline in cognitively intact older adults are needed to further evalu-
ate and implement this potential.
1.2. Functional magnetic resonance imaging of risk and prognosis
Functional magnetic resonance imaging (fMRI) has considerable
promise as an effective preclinical biomarker of AD. Because task-
activated fMRI relies on the capability to carry out speciﬁc cogni-
tive tasks, it is sensitive to the dynamic functional integrity of the
brain. Therefore, fMRI may be able to reveal early abnormalities
in brain function that could reﬂect the initial stages of AD neuropa-
thology. Indeed, analysis of the task-activated blood-oxygen-level-
dependent (BOLD) signal has yielded successful prediction of con-
version from MCI to AD [43–45]. A limited number of studies
have also used fMRI to predict subsequent cognitive decline in cog-
nitively intact older adults [46–50]. Having a genetic predisposition
to develop AD (i.e. presence of the APOE e4 allele) has been dem-
onstrated to inﬂuence the BOLD signal in asymptomatic older adults
[51–53]. Similar risk-related alterations of the BOLD signal have been
observed throughout adulthood [54–58], suggesting that factors in-
cluding the APOE ε4 allele and a family history of AD inﬂuence
brain functioning across the lifespan. Given these factors, fMRI bio-
markers may allow for more accurate prediction of cognitive decline
over sMRI, family history, and APOE genotype information alone [48].
1.3. Overview
In this review, we will present a summary of work from cross-
sectional and longitudinal studies investigating imaging strategies
for early detection of cognitive decline. Our collaborative research
group has focused on identiﬁcation of the neural correlates of se-
mantic memory to investigate early prediction of cognitive decline.
Using person-identity memory as a foundation, we evaluated face
and name discrimination and subsequently developed a famous
name discrimination task. fMRI activation associated with this task
has successfully differentiated younger control participants from
cognitively intact older adults [59], healthy older APOE ε4 carriers
from non-carriers [52], and persons with amnestic MCI from olderhealthy and at-risk controls [60]. The task has also assisted in con-
trasting theories of age-related neural network change [59,61,62],
to evaluate hypotheses regarding the relative roles of the neocortex
and the medial temporal lobe in the retrieval of recent and remote
semantic memories, and to investigate the nature of temporally
graded remote memory retrieval [61,62]. Recently, we have devel-
oped a prediction model to assist in identifying cognitively intact
older adults who were at the greatest risk of cognitive decline
[48], and we evaluated the effects of self-reported physical activity
on alteration of semantic memory activation in healthy older adults
[63] and MCI patients [64].
Our results, in addition to research ﬁndings from several other lab-
oratories, suggest that fMRI during semantic processing tasks may
provide advantages over episodic memory tasks in the assessment
of risk for AD and prognosis for future cognitive decline. The present
work will review research conducted by our lab and others on the
functional correlates of semantic memory with regard to aging, AD
risk, cognitive decline, and MCI. Future directions for research and
the viability of fMRI in a clinical setting will also be discussed.
2. Semantic memory task development, results and implications
for memory theories
2.1. Episodic vs. semantic memory in AD biomarker research
A number of fMRI studies engage participants in various tasks in-
volving aspects of memory functioning. Two general categories of
memory performance are frequently assessed — episodic memory
(e.g. discriminating between previously learned and novel stimuli)
and semantic (recall of general facts and knowledge about the
world that is not contextually speciﬁc, e.g. making a categorical or at-
tributional judgment to a presented item). Given that episodic mem-
ory impairment is a hallmark of AD [65], most fMRI studies of AD risk
have used episodic memory tasks [53]. However, the use of episodic
memory tasks in fMRI studies that focus on prediction of MCI, AD,
and risk factors for these conditions may present challenges. Episodic
memory impairment is typically observed not only in association
with symptom onset of MCI or AD [66–70], but declines in episodic
memory performance are also observed in normal aging [71]. There-
fore, disparities in task performance between participants and groups
may confound results. Discrepancies in the BOLD signal between par-
ticipants during episodic memory tasks may therefore be a product of
neuropathology or age-related differences in task performance (or
both). However, for the purposes of fMRI biomarker research, the
question of interest focuses primarily on the extent to which neuro-
pathology inﬂuences the brain's hemodynamic response during cog-
nitive processing; imaging is not necessary to assess age-related
memory performance differences. Furthermore, episodic memory
tasks may also be inherently more difﬁcult than semantic memory
tasks, and individuals who are in the preliminary stages of cognitive
decline may exert greater effort and may paradoxically display a
greater BOLD signal due to the increased cognitive challenge. Indeed,
in longitudinal studies utilizing episodic memory tasks, participants
who display a greater extent of activation are typically at the greatest
risk of subsequent cognitive decline [46,49,50].
The use of semantic memory tasks during fMRI may provide several
advantages over episodic tasks. Semantic memory tasks involve imme-
diate, context-independent familiarity with previously learned infor-
mation, and they are typically easier and less frustrating for older
participants to complete than episodic tasks. Unlike episodic memory
skills, semantic memory abilities remain relatively intact with normal
aging [71] but are commonly affected during AD [72–74]. In studies
of risk, between-group discrepancies in task performance are not fre-
quently observed, because all participants can perform with a high de-
gree of accuracy [48,52]. Contrary to the results from longitudinal
episodic memory studies [46,49,50], participants who exhibit lower
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of future cognitive decline [47,48]. Furthermore, regions that are
typically activated during semantic memory retrieval overlap with
those associated with the default mode network [75] as well as
with regions that are the most susceptible to neuropathological
changes associated with AD [76]. Thus, analysis of the BOLD signal
during semantic memory processing has a number of advantages
over episodic memory for discriminating between healthy aging
and disease-related changes and risk.
Several semantic processing tasks have been utilized in functional
imaging studies. The most common contrasts [75] include semantic
versus phonological word judgments (e.g. [77,78]), discriminating
between words and pseudowords (e.g. [79,80]), high versus low
meaningfulness judgments (e.g. related and unrelated word pairs,
[81,82]), and comparing members of speciﬁc categories (e.g. concrete
or abstract words, [83,84]). Considerable research has also been
dedicated to tasks involving person identity, such as the recognition
of famous and unfamiliar names or faces [85–91], which reﬂects a
semantic meaningfulness dimension (e.g., meaningful vs. non-
meaningful) [75]. When contrasting the recognition of famous
names with the correct rejection of unfamiliar names, activation
has been observed in a variety of neocortical and medial temporal
lobe (MTL) regions, including the hippocampus [61,62]. Our research
has focused on this paradigm to investigate the neural correlates of per-
son identity and memories of different ages, and how these processes
may be affected by aging and risk for AD. In the following sections, we
describe the development and preliminary usage of our famous
and unfamiliar name stimuli.
2.2. Episodic and semantic memory networks during face recognition
The ﬁrst study of the long-term, semantic memory network by our
group [92] involved the use of fMRI during familiarity judgments of fa-
mous and recently learned faces. Our initial focus was to contrast the
neural correlates of semantic and episodic memory with regard to per-
son identity. Participants were instructed to learn and remember novel,
unfamiliar pictures of faces during an encoding phase. During a retrieval
phase, participants were asked to determine whether a presented face
was familiar or unfamiliar. Familiar faces were either previously seen
during the encoding phase or were famous individuals, and unfamiliar
faces were non-famous foils. The famous faces consisted of well-
known entertainers, politicians, and sports ﬁgures from the previous
30 years. Thus, this paradigm allowed for direct comparison between
the neural networks associatedwith two distinct retrieval memory sys-
tems: newly learned episodic memory (from the encoding phase) and
long-term semantic memory (famous faces).
Compared to the correct rejection of unfamiliar faces, recognition
of newly learned faces induced a left-lateralized cortical pattern of
fMRI activation. Greater activation was observed for unfamiliar faces
over newly learned faces in several bilateral frontal regions and the
right fusiform gyrus. In contrast, recognition of famous faces activated
an extensive bilateral network incorporating both cortical and subcortical
regions, compared to newly learned and unfamiliar faces. Importantly,
greater activationwas observed inMTL structures, including the left hip-
pocampus and right parahippocampal gyrus. Behavioral differences
could not account for the discrepancy in neural recruitment between
newly learned and famous faces. Thus, this low effort, high accuracy se-
mantic processing task, which is usable in large segments of the popula-
tion due to the high familiarity of the stimuli, activated an extensive
bilateral network associated with the recognition of well-known
individuals.
A critical question of interest iswhether pictures of faces andwritten
names of familiar individuals are processed in similar brain regions or
whether the mental representation of this person-identity material
may engage different brain regions. In addition, face stimuli tend to con-
tain complex visual information, including affective valence (e.g. theindividual is typically smiling), variations along an attractiveness con-
tinuum, and other visual details (e.g. hair style, presence of facial hair,
clothing). Name stimuli tend to be more uniform in terms of the visual
stimulus that is presented (i.e. letters). Therefore, name stimuli may
have advantages over face stimuli in terms of reducing the complexity
of the material presented to participants. The ability to present names
of individuals who became famous in different eras also affords the op-
portunity to explore the brain's responses during activation of memo-
ries of different ages.
2.3. Development and pilot testing of famous names
We sought to identify the patterns of neural activity associated with
the recognition of persons from different time periods to determine
whether the brain exhibits a temporally graded pattern of regional re-
cruitment in response to memories of different ages. To address these
questions, we developed a list of famous and unfamiliar names that
could be reliably categorized by older and younger individuals alike
[62]. We identiﬁed entertainers, politicians, criminals, or athletes who
achieved public prominence either between approximately 1990 and
2000 (Recent famous names) or between approximately 1950 and
1965 (Remote famous names). Unfamiliar names were randomly select-
ed from a local phone book as a control condition. Following pilot testing
with older and younger adults, we created aﬁnal list of 30 names in each
of four categories. Unfamiliar names were selected for inclusion on the
ﬁnal list if they were correctly identiﬁed as non-famous by 90% of both
older and younger participants. Recent famous names from the 1990s
(e.g. George Clooney, Colin Powell) were correctly identiﬁed as famous
by at least 90% of both younger and older adults. Enduring famous
names (individuals who achieved fame between 1950 and 1965 and
are still well known today; e.g. John F. Kennedy, Marilyn Monroe) were
also correctly identiﬁed as famous by at least 90% of both younger and
older adults. Our fourth category, Remote famous names, consisted of in-
dividuals who achieved fame between 1950 and 1965 and who were
correctly identiﬁed by at least 90% of older adults and by no more than
30% of younger participants. This latter stimulus category was designed
to represent famous names that would be easily recognizable to older
adults while being out of the public eye for several decades. Therefore,
correct identiﬁcation of these stimuli was thought to reﬂect retrieval of
remote semantic material without being contaminated by recent updat-
ing. In this task, participants are required to categorize each name as fa-
mous or unfamiliar. Thus, the task is known as the famous name
discrimination task (FNDT).
2.4. Famous name recognition of recent and remote memories
Our initial study using the FNDT investigated functional activity spe-
ciﬁcally in the hippocampal complex and parahippocampal gyrus (PHG)
in response to Recent, Remote, and Unfamiliar names [62]. A goal of this
study was to contrast predictions of two models of hippocampal func-
tioning: Hippocampal Consolidation [93] and Multiple Trace Theory
[94]. According to the Hippocampal Consolidation model, the hippo-
campus guides the formation of memory representations in the neocor-
tex and serves only a time-limited role in memory retrieval. In contrast,
Multiple Trace Theory posits that successful memory retrieval relies on
the interaction between the hippocampus and neocortex, and the hip-
pocampus is involved as long as the memory is available. Analysis of
memories of different ages, such as the recognition of famous names
from Recent and Remote time periods, presents the opportunity to test
these competing theories. The Hippocampal Consolidation model
would predict that hippocampal activation would be observed for
Recent but not Remote names, and Multiple Trace Theory predicts
that hippocampal activation would be seen in response to names
from both time epochs.
Cognitively intact older adults completed the FNDT during event-
related task-activated fMRI. Bilateral activation was observed in both
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ognition compared to Unfamiliar names, substantiating the participa-
tion of MTL structures during long-term recognition memory.
However, a temporally graded retrieval pattern was observed in the
right MTL, but not in the left MTL. That is, greater activation in both
the right hippocampus and PHG was observed during recognition of
Recent famous names relative to Remote famous names. No signiﬁ-
cant activation differences between Recent and Remote famous
names were observed in the left MTL (Fig. 1).
A subsequent report [61] utilizing the same imaging dataset exam-
ined patterns of neocortical activation associated with the recognition
of Recent and Remote famous names. Both Recent and Remote names
recruited an extensive bilateral pattern of cortical regions compared to
Unfamiliar names, including regions in the frontal, temporal and parietal
lobes. A temporally graded retrieval pattern was also observed in poste-
rior cingulate cortex (PCC), with greater activation during RecentFig. 1. From reference [62]. Temporally gradedMTL activation during the FNDT. (A) Anatomical
response functions for recent (90s) and remote (50s) famous names and foils (FO). Note the te
between four and eight seconds post stimulus onset revealed greater activation for recent comp
pal gyrus. Error bars reﬂect the standard error of the mean. Figure reproduced with permissiocompared to Remote name recognition (Fig. 2). The PCC has extensive
connections to frontal cortex [95] as well as to the MTL [96–98], and
it appears to play amajor role in the neural circuitry involved in both ep-
isodic [99] and semantic [75] memory retrieval. Additionally, a number
of studies have demonstrated hypometabolism, hypoperfusion, or de-
creased activation in the PCC in individuals with MCI [38,100] or AD
[101–103].
Theﬁndings of these two studies [61,62] have implications regarding
the relative contributions ofMTL and cortical regionsduringmemory re-
trieval. The MTL activation associated with famous name recognition
memory [62] primarily supported theMultiple Trace Theory [94] of hip-
pocampal functioning, because greater hippocampal complex activity
was observed during correct identiﬁcation of both Recent and Remote
famous names relative to the rejection of Unfamiliar names. However,
evidence of temporally graded memory retrieval observed in the right
MTL and PCC also provided some support for the Hippocampalmaps ofMTL structures for a typical cognitively intact older participant. (B) Hemodynamic
mporal gradient present in the right MTL structures. Area under the curve (AUC) analyses
ared to remote famous names in both the right hippocampal complex and parahippocam-
n.
Fig. 2. From reference [61]. Temporally graded neocortical activation during the FNDT. Four regions that demonstrated evidence of a temporally graded response to names from
different time epochs are depicted with anatomical localization and full time-course, group-averaged hemodynamic response functions (HRFs). Signiﬁcant time epoch differences
were identiﬁed using estimates of the hemodynamic response (AUC for 4–8 s poststimulus). Error bars reﬂect the standard error of measurement at each time point. Figure repro-
duced with permission.
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hippocampal activation than Recent names, this pattern suggests that
older memories may be predominantly stored in neocortical rather
than in hippocampal regions. A similar pattern of temporally graded ac-
tivity in theMTL during famous face recognition has also been reported,
with greater activation in response to recently learned faces being ob-
served in the right entorhinal cortex [90]. However, evidence support-
ing the presence of a temporal gradient in the hippocampus during
famous face recognition has been mixed, with one study observing no
difference between recent and remote faces [88] and another showing
greater activation in response to recent faces in right hippocampus
only [90]. Despite these mixed ﬁndings associated with the temporal
gradient, identiﬁcation of famous faces and names appears to reliably
engage both hippocampal and neocortical regions. Differences across
studies in the deﬁnitions of recent and remote time epochs and the na-
ture of the stimuli themselves (e.g. visual characteristics of face stimuli)
could possibly account for the variability in ﬁndings. Robust evidence
supporting evidence of the Hippocampal Consolidation model has
been demonstrated using episodic recognition of newly-learned photo-
graphs over a 3-month interval [104].
2.5. Face vs. name recognition
Differences in activation patterns between famous names and fa-
mous faces noted across the studies described above prompted us to
investigate whether there are common and/or unique neural network
components subserving famous face and name recognition [105].
Using the stimuli described above [59,92], young adult participants
viewed famous and unfamiliar faces and names during task-activat-
ed fMRI. Although recognition performance exceeded 90% for all
stimulus types, accuracy was signiﬁcantly better for names than
for faces. Collapsed across famous and unfamiliar stimuli, each pre-
sentation modality activated distinct regions, most notably bilateral
fusiform and lateral occipital regions for faces relative to names and
diffuse left neocortical regions for names relative to faces. However,
when collapsed across stimulus type, there was a distinct pattern of
overlapping neural activation for famous compared to unfamiliar
stimuli. This “fame network” consisted of bilateral hippocampal re-
gions in addition to regions in the left frontal, insular, temporal,and parietal lobes, and posterior cingulate. The presence of common
regions between both famous face and name recognition suggests
that these areas are involved with person identity semantic memo-
ry, regardless of presentation modality.
The preceding studies were helpful in validating the FNDT for use
in studying semanticmemory processes associatedwith person-identity
information and enabled us to investigate aspects of the cognitive
neuroscience associated with fame recognition. The following sections
will discuss the use of the FNDT and semantic memory activity in the
study of normal and pathological aging.
3. Integrity of semantic processing as a biomarker
3.1. Age-related differences in semantic processing
Previous neuroimaging research has demonstrated that compared
to younger adults, older adults typically display amorewidespread pat-
tern of fMRI activationwith reduced hemispheric asymmetry [106,107].
A potential explanation for these ﬁndings is that the increased activa-
tion represents compensatory recruitment of additional resources to
achieve equivalent cognitive performance, despite declining brain func-
tion. An alternative but not mutually exclusive hypothesis suggests that
the specialization of neural regions decreaseswith age, resulting in ded-
ifferentiated, more diffuse patterns of activation. Using the FNDT, we
have observed similar compensatory patterns of increased fMRI activity
during semantic memory retrieval in older compared to younger adults
[59].
Younger and older adult participants completed the FNDT during
fMRI. In 15 out of 20 neocortical and MTL regions (including the
right hippocampus), older adults exhibited a greater magnitude and
spatial extent of activation than younger adults. Younger adults did
not demonstrate greater activation than older participants in any re-
gion. The difference between groups was particularly large for Recent
names, with greater activation observed for older adults in all 15 re-
gions, whereas greater activation for Enduring names was observed
in 7 out of the 15 regions. The selectively greater activation observed
in older compared to younger adults provides evidence for compen-
satory recruitment during semantic memory retrieval, even though
task accuracy was comparable to younger adults.
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mantic processing and aging. One study [108] observed reduced acti-
vation in older compared to younger participants during a semantic
word judgment task (concrete vs. abstract) in left prefrontal cortex,
and older participants did not recruit additional regions compared
to younger adults. Another study [109] reported that younger and
older adults recruited mainly overlapping regions of neocortex during
semantic word encoding (living vs. non-living), but a greater magni-
tude of activation in younger adults was observed in the left hippo-
campus. The authors of these studies argue that frontal and MTL
regions subserving semantic encoding may be functionally deﬁcient
in older adults. Although compensatory recruitment was not ob-
served in these studies, the hypothesized functional deﬁciencies
may assist in explaining why additional regions appear to have
been recruited in other fMRI studies assessing episodic memory
[106] or the FNDT [59].3.2. Evidence for compensatory recruitment associated with risk for AD
According to the Scaffolding Theory of Aging and Cognition (STAC;
[107]), the recruitment of additional neural circuitry during task per-
formance occurs to support structures with declining functional in-
tegrity. This additional recruitment may reﬂect an essential
component of healthy, adaptive cognitive aging. For example, a study
using PET [110] observed greater hemispheric asymmetry during an ep-
isodic memory task in older adults who performed well compared to
those who did poorly on the task, suggesting that “scaffolding” is bene-
ﬁcial for maintaining late-life cognition. Another study [111] observed
that increased prefrontal activity in AD patients was correlated with
better performance on both episodic and semantic memory tasks.
Such scaffolding may occur across the lifespan, although in older indi-
viduals this adaptation may be more common and necessary due
to the accumulated deterioration of neural circuitry. The additional
recruitment in response to task demands is reﬂected by increased
regional brain activation.
Scaffolding has been observed in those at the greatest risk for late-
life degenerative conditions, such as AD, prior to the onset of clinical
symptoms. For example, one study [51] observed greater magnitude
and spatial extent of activation during an episodic picture encoding
task in older adults who were carriers of the APOE ε4 allele compared
to non-carriers, even though all participants were non-demented and
had normal memory functioning. A similar compensatory response
was observed in right hemisphere regions of older, non-demented
APOE ε4 carriers during a verbal episodic encoding task compared to
non-carriers [112]. This risk-related scaffolding pattern has been ob-
served to occur throughoutmiddle age and late-life. In a cross-sectional
study [56], right hippocampal activation during episodic encoding de-
creasedwith age in low risk participants (APOE ε4 non-carrierswithout
a ﬁrst-degree family history of dementia). However, right hippocampal
activation increasedwith age in APOE ε4 carriers and thosewith a family
history of dementia, with the greatest increases observed in persons
with both risk factors. Furthermore, greater bilateral hippocampal acti-
vation has been observed even in young adult APOE ε4 carriers com-
pared to non-carriers during episodic picture encoding [57].
Not all studies examining the effects of the APOE ε4 allele have ob-
served increased recruitment. Some studies have observed a reduced
signal in APOE ε4 carriers [113,114], whereas other studies reported
no differences between groups [115,116]. The nature of the effects
may vary with the choice of task, stimuli, or region studied [53]. How-
ever, these studies of altered patterns of activation associated with
risk factors for dementia are consistent with evidence that AD pathol-
ogy may accumulate over decades prior to clinical onset [10,11].
According to STAC, the compensatory recruitment pattern would
imply that possession of these risk factors is associated with declining
functional integrity despite equivalent task performance.Limited research has examined the effects of risk on functional activa-
tion during semantic memory processing. One study [117] reported de-
creased activity in APOE ε4 carriers compared to non-carriers during a
word categorization paradigm relative to a baseline passive ﬁxation con-
dition, in regions in the anterior cingulate and left parietal lobe. However,
a follow-up report from the same dataset [118] indicated that APOE ε4
carriers had reduced deactivation from baseline due to abnormalities in
the default mode (or “resting state”) network. Thus, the interpretation
of the previous study [117] is tempered by the choice of passive ﬁxation
as a comparison condition. Using the FNDT, which uses active identiﬁca-
tion of unfamiliar names as a comparison condition for active recognition
of famous names, we observed evidence of compensatory recruitment in
asymptomatic older adults at-risk for AD during semantic memory pro-
cessing [52].
Cognitively intact older adults were divided into three groups
based on genetic risk for AD: APOE ε4 carriers with a family history
of dementia in a ﬁrst degree relative (FH+ε4), APOE ε4 non-carriers
with a family history of dementia (FH), and control participants with
neither risk factor (CON). During the FNDT, both at-risk groups dem-
onstrated nearly completely independent regions of activation from
the control group. Moreover, the control group displayed predomi-
nantly greater activation during the presentation of unfamiliar
names, whereas the at-risk groups had a greater response to famous
names. Overall, the FH+ε4 had a greater volume of activation in re-
sponse to famous relative to unfamiliar names than the FH group
(Fig. 3). The results of this study are consistent with the aforemen-
tioned studies that demonstrated the impact of risk factors for AD
on the BOLD signal prior to the onset of cognitive symptoms. The ad-
ditional neural recruitment observed during semantic memory re-
trieval in those at genetic risk for AD provides evidence supporting
STAC and the declining integrity of neural resources in these individ-
uals. Moreover, the impact of risk factors appeared to be additive,
with the greatest functional recruitment being observed in individ-
uals with both risk factors. These results could not be explained by
differences in task performance or effort, as all groups exhibited
equivalent accuracy and reaction times. Importantly, the striking dif-
ferences in brain activation maps between persons with and without
risk factors for AD highlighted the potential use of the FNDT as a
method for assessing presymptomatic dementia risk. However, limi-
tations of this and other studies of risk include that they are cross-
sectional, and the altered activation patterns are not necessarily evi-
dence of increased risk. Longitudinal studies are necessary to determine
the predictive utility of fMRI (discussed in Section 3.4).
3.3. Altered activation in MCI patients
In addition to revealing early abnormalities in patterns of activa-
tion that may reﬂect AD risk in cognitively intact older adults, altered
semantic memory processing has been reported in individuals with
MCI. A diagnosis of MCI typically precedes AD, although not all
cases will progress to dementia [119]. MCI is characterized by deﬁcits
in both episodic and semantic memory systems [120,121]. Several
previous fMRI studies have observed differences in the BOLD signal
associated with episodic memory processing between MCI patients
and age-matched controls [122–126]. However, it should be noted
that these studies used generally effortful episodic memory tasks,
and in one study [126], MCI patients performed signiﬁcantly worse
than controls. While this discrepancy in performance was not univer-
sally observed in the aforementioned studies, it is nonetheless difﬁ-
cult to interpret between-group fMRI data when differences in
motivation and cognitive performance are potential confounds
[127]. The use of a low effort, high accuracy task provides advantages
for the examination of MCI-related alterations to the BOLD signal, be-
cause all subjects can perform at high levels. One previous study [128]
utilized a lexical decision task that MCI patients were able to perform
with comparable accuracy relative to controls. The results revealed a
Fig. 3. From reference [52]. Effects of risk factors for AD on functional memory recruitment during famous compared to unfamiliar names. Note the greater activation for unfamiliar
names in control (CON) participants and the opposite patterns in the at-risk groups (FH and FH+ε4). Also note the dose-dependent effects of risk factors on recruitment, with the
greatest activation observed in the FH+ε4 group. Figure reproduced with permission.
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vation in bilateral anterior cingulate cortex and hypoactivation in bi-
lateral fusiform and left occipitotemporal and inferior frontal
regions in MCI patients relative to controls. Furthermore, there was
no evidence of atrophy in these regions in the MCI patients. Another
study [129] investigated fMRI activation during a semantic word as-
sociation task and observed equivalent performance betweenMCI pa-
tients and controls. Compared to a size discrimination control
condition, MCI patients displayed hypoactivation relative to controls
in the posterior third of the lower bank of the superior temporal sul-
cus. The results of these studies suggest that patterns of fMRI activa-
tion can reliably identify abnormal functioning in neocortical
regions and can be used to distinguish between MCI patients and
cognitively intact older adults, even when task performance is
comparable.
We have demonstrated evidence of compensatory recruitment dur-
ing semantic memory retrieval in MCI patients using the FNDT [60].
Older adults with MCI (according to Petersen criteria [130]) and cogni-
tively intact controls with or without the APOE ε4 allele (“high-risk”
and “low-risk” groups, respectively) served as study participants. Impor-
tantly, the three groups did not differ on task performance. Consistent
with our previous work [52], high-risk controls displayed greater activa-
tion than low-risk controls for famous relative to unfamiliar names inseveral MTL and neocortical regions. Interestingly, MCI patients dis-
played a similar compensatory response, with a greater extent andmag-
nitude of activation across a number of brain regions compared to both
high- and low-risk controls.
This study [60] demonstrated evidence for compensatory recruit-
ment and/or scaffolding, which may reﬂect compensation for func-
tional deﬁcits in the neural networks subserving semantic memory
in MCI patients. Importantly, these differences were observed when
task performance was equivalent between groups. While semantic
memory impairment is commonly associated with MCI [120,121],
our participants were still able to perform this relatively simple task
at a high level of accuracy. Thus, activation associated with semantic
processing of person-identity information can be used to identify ab-
normal patterns of activation in older individuals who have experi-
enced cognitive impairment. Subsequent research from our group
has focused on evaluating the FNDT for use as a predictor of cognitive
decline in asymptomatic older adults.
3.4. Longitudinal prediction of cognitive decline
A limited number of longitudinal studies (see Section 1.1) have
attempted to use patterns of fMRI activation to predict cognitive de-
cline in cognitively intact older adults [46,47,49,50]. In many of
Fig. 4. From reference [48]. Baseline fMRI activation used in the prediction model of
cognitive decline, highlighting group differences in activation derived from the com-
parison of the famous and unfamiliar names conditions: FamousNUnfamiliar is in
red, UnfamiliarNFamous in blue. Note the greater spatial extent of activation in the
FamousNUnfamiliar names comparison in the Stable compared to the Declining
group. Figure reproduced with permission.
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regions or hippocampus [50] at baseline was indicative of an in-
creased risk for subsequent decline. Other longitudinal studies
[43,44] have examined the value of task-activated fMRI for the pre-
diction of the conversion fromMCI to AD. In these studies, greater ac-
tivation was again associated with a poorer prognosis, either when
observed in the hippocampus during episodic encoding [43] or in pa-
rietal regions during an angle discrimination task [44]. We recently
reported contrasting ﬁndings from a longitudinal prediction study
utilizing a semantic processing task [48].
Cognitively intact older adults were compared on neuropsycho-
logical testing, sMRI, and the FNDT during fMRI at baseline versus at
18-month follow-up. Participants were recruited from newspaper ad-
vertisements, and half were selected on the basis of a family history of
dementia in a ﬁrst-degree relative. Thus, our sample was enriched
with a greater proportion of APOE ε4 carriers than in the general pop-
ulation, as this allele is more common in individuals with a family his-
tory of dementia [54,131]. At follow-up, 34.6% of participants
exhibited cognitive decline, deﬁned as a performance deﬁcit of at
least one SD compared to the predicted value on one or more of
three neuropsychological outcome measures (Mattis Dementia Rat-
ing Scale-2 [132–134], Rey Auditory Verbal Learning Test (AVLT)
Sum of Trials 1–5 and AVLT Delayed Recall [135]). Given the relatively
brief follow-up period, the purpose of this study was not to predict
cognitive impairment or MCI status (only 7.4% of declining partici-
pants met Petersen criteria for MCI [130] after 18 months), but rather
to predict a one SD or greater decline in performance that may repre-
sent the early phases of MCI or dementia. Although it is possible that
other factors may have accounted for decline in some participants,
the majority of participants who declined by one SD at follow-up con-
tinued to exhibit decline at ﬁve-year follow-up (unpublished data).
Stable and declining participants had equivalent FNDT perfor-
mance at baseline. Notably, participants with greater fMRI activation
at baseline were less likely to have exhibited cognitive decline at
follow-up. Logistic regression analyses demonstrated that lower
activation during the FNDT in cortical and hippocampal regions,
smaller bilateral hippocampal volume (as determined by manually-
traced sMRI), and presence of the APOE ε4 allele were each indepen-
dently associated with a greater risk of cognitive decline at 18-month
follow-up (Fig. 4). Thus, baseline semantic memory activation provided
predictive information regarding future cognitive decline above and be-
yond genetic risk and hippocampal volume. Even though the reduced
hippocampal activation in the declining group may have been due
to atrophy, the activation still functioned as an independent predictor
of decline. Consistent with our cross-sectional studies [52,60], carriers
of the APOE ε4 allele displayed greater activation in response to famous
relative to unfamiliar names at baseline than non-carriers. However, for
both APOE ε4 carriers and non-carriers, greater BOLD signal activation
was associated with a reduced probability of decline.
These results appear to contradict previous longitudinal studies
that used fMRI to predict cognitive decline [46,50], where greater
baseline activation was associated with a poorer prognosis. However,
an important difference in our study was the use of a low effort, high
accuracy semantic memory paradigm, as opposed to an episodic
memory task. Our results are consistent with another longitudinal
study that observed that greater activation in a left parietal region
during semantic word classiﬁcation was associated with a reduced in-
cidence of future cognitive decline [47]. Because episodic tasks are
cognitively demanding, greater activation in declining participants
could reﬂect the additional cognitive effort necessary to complete
the tasks. This additional exertion could be the product of declining
functional integrity in neural resources, hence the greater probability
of subsequent cognitive decline. In contrast, greater fMRI activation
during semantic processing tasks could represent a healthy, adaptive
response to combat declining neural resources that is protective
against future degeneration, consistent with STAC [107].Recently, we reported advantages of semantic processing tasks
over episodic memory tasks for the prediction of cognitive decline
[136], which may have important implications for the use of fMRI as
a clinical biomarker for cognitive decline and dementia. The partici-
pants from our longitudinal study [48] completed an episodic memory
task at baseline after the semantic task, during which they were re-
quired to discriminate between names presented during the semantic
trial and novel famous and unfamiliar names. Accuracy was equiv-
alent between cognitively stable and declining participants for all
stimulus conditions, although accuracy was much poorer for the
episodic task.
A principal components analysis revealed a network of subcortical,
parietal/temporal, and frontal activation associated with identiﬁcation
of previously seen relative to novel names. Logistic regression analyses
revealed that only increased subcortical activation (including bilateral
caudate and thalamus) was associated with a higher predicted proba-
bility of decline. However, the predictive utility of the episodic memo-
ry-induced fMRI regional activation components was inferior to the
regional activation induced by the FNDT. The semantic task's enhanced
sensitivity to probability of future decline may be due in part to the
overlap between the semantic memory and default mode networks
[75].
In a recent meta-analysis of fMRI studies using semantic proces-
sing tasks [75], a left-lateralized network was identiﬁed as being cru-
cial to semantic retrieval. This network included seven regions —
posterior inferior parietal lobe, middle temporal gyrus, fusiform and
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gyrus, ventromedial prefrontal cortex, and posterior cingulate gyrus.
We have observed activation in all of these regions when contrasting
famous relative to unfamiliar name recognition with the FNDT [61].
Additionally, this meta-analysis suggested that these regions appear
to overlap with areas commonly associated with the default mode,
or “resting state” network [75]. This network typically displays deac-
tivation during task engagement in healthy controls, and reduced
task-activated inhibition of the default mode network has been ob-
served in older compared to younger adults [137], as well as in MCI
and AD patients compared to age-matched controls [137,138]. Fur-
thermore, reductions in default mode deactivation have been ob-
served in asymptomatic APOE ε4 carriers compared to non-carriers
[57] and have been associated with an increased risk for the conver-
sion from MCI to AD [45]. One group [76] noted that regions com-
monly associated with the default mode network parallel the
regional distribution of amyloid-beta plaques that are common in
the early phases of AD, and they postulated that the continuous activity
of these regions throughout life may increase the susceptibility to this
late-life pathology. This “Metabolism Hypothesis” would imply that
overuse of these regions confers a greater risk for AD pathology. Given
the overlap between the semantic memory and default mode networks
[75], this assertionmay help to explainwhy semanticmemory tasks are
sensitive to AD risk and likelihood of cognitive decline.
3.5. Associations with physical activity
Our review of the literature suggests that task-activated fMRI pro-
vides predictive information concerning cognitive decline in asymptom-
atic older adults. Various other biomarkers [16] and lifestyle behaviors
[3] have been identiﬁed as risk factors for cognitive decline and AD.
Thus, the most effective combination for prediction models may consist
of fMRI combinedwith other relevant variables. One area of researchhas
investigated the inﬂuence of physical activity (PA), which has been
identiﬁed as a possible protective factor involved in maintaining late-
life cognitive functioning [5]. Although the speciﬁc neural mechanisms
bywhich PAmight confer resistance to decline are still largely unknown,
some candidates have emerged. Exercise interventions (such as wheel
running) in rodents increase levels of brain-derived neurotrophic factor
(BDNF), which, in turn, promotes synaptogenesis, neurogenesis, and
plasticity [139–143].
Recently, PA has been demonstrated to increase brain tissue volume
in older humans, potentially as a result of exercise-mediated neurogen-
esis [144]. Physically inactive elderly adults were randomly assigned to
aerobic exercise (walking) or stretching (control) conditions. At six-
month and one-year follow-up, bilateral hippocampal volume as mea-
sured by sMRI increased in the aerobic exercise group, whereas hippo-
campal volume decreased in the stretching group. The greatest
differences were observed in bilateral anterior hippocampus, which
contains the dentate gyrus, a site of adult neurogenesis [139].Moreover,
elevations in serum BDNF compared to baseline were associated with
greater volume increases in bilateral anterior hippocampus, substanti-
ating the role of neurogenesis as a potential mechanism by which PA
may delay AD-related neuropathology and hippocampal atrophy. Addi-
tionally, the aerobic exercise group displayed an improvement in spatial
memory abilities compared to control participants.
We recently observed fMRI evidence of the protective effects of PA
on brain functioning [63]. Using a previously validated measure of PA
for older adults (the Stanford Brief Activities Survey; [145,146]), we
separated cognitively intact older adults into four groups: Low Risk/
Low PA, Low Risk/High PA, High Risk/Low PA, and High Risk/High
PA. Risk was deﬁned as the presence or absence of the APOE ε4 allele.
Consistent with our previous research [48,52,60], High Risk partici-
pants displayed a greater extent and magnitude of activation com-
pared to Low Risk individuals during the FNDT. Interestingly, High
PA participants displayed greater semantic memory activation thanLow PA in several frontal and temporal regions. Furthermore, an in-
teraction between risk and PA indicated that the elevated activation
associated with engagement in PA was greater for High Risk than
Low Risk participants. Interaction effects (deﬁned as a familywise
error threshold of pb .01) were observed in predominately left hemi-
sphere neocortical regions (Fig. 5). Combined with our previous lon-
gitudinal study [48], these ﬁndings imply that High PA participants
may be at reduced risk for cognitive decline, with the beneﬁcial effects
of PA being potentiated in those at genetic risk for dementia.
A follow-up study [147] supported the prognostic implications of
the relationship between PA and the BOLD signal. PA was added as
a variable to the 18-month prediction models developed from the
participants from our longitudinal study [48]. In a model including
hippocampal activation, APOE ε4 allele status, PA, and the interaction
between APOE and PA, PA alone was not a signiﬁcant predictor of
cognitive decline, but the interaction effect was signiﬁcant. This result
indicated that PA can provide information regarding prognosis for
cognitive decline beyond genetic and fMRI variables alone. Analysis
of the simple effects revealed that the protective effects of PA in re-
ducing the probability of cognitive decline were limited to APOE ε4
carriers, in concordance with the results of our previous study [63].
Moreover, in APOE ε4 carriers, the effects of PA were non-signiﬁcant
in participants with below average (in our sample) hippocampal vol-
ume or semantic memory activation, suggesting that PA may be more
beneﬁcial for older adults with strong hippocampal integrity. Thus, in-
formation concerning leisure engagement in PA may enhance predic-
tion of cognitive decline over fMRI, sMRI, and genetic variables alone,
and optimal prediction may include the assessment of several factors.
The enhanced protective effects of PA for APOE ε4 carriers compared
to non-carriers have been reported in other studies as well [148–150],
although one notable study found the opposite interaction. In that lon-
gitudinal study, greater engagement in PA was associated with a re-
duced risk for dementia in APOE ε4 non-carriers only [151]. Further
research is necessary to determine the exact nature of this interaction,
but at present, our results suggest that the potential of PA as a late-life
intervention to delay or prevent cognitive decline may be limited (or
at least maximally beneﬁcial) to those at genetic risk for AD.
A recent report by our group also suggests that PAmay be protective
against further cognitive decline in amnesticMCI patients [64]. Nine Low
PA and nine High PA MCI patients, matched on demographic variables,
completed the FNDT. Greater activation for famous relative to unfamiliar
names was observed in High PA compared to Low PA participants in the
left caudate nucleus. Reductions in caudate volume have been associat-
ed withMCI and an increased risk for conversion to AD [152,153]. These
results suggest that PA may assist in preserving caudate integrity and
may reduce the risk of conversion to AD, even though no group differ-
ences were observed in caudate volume in our sample. A longitudinal
follow-up is necessary to assess the validity of this postulation. A limita-
tion of this study and the other PA studies by our group [63,147] is that
our measure of PA [145,146] is based on self-report, and the studies are
purely observational in nature. Controlled intervention studies are nec-
essary to validate the protective value of PA for the late-lifemaintenance
of cognitive functioning.
4. Summary and future directions
4.1. Semantic memory probes as a clinical biomarker
The use of a low effort, high accuracy task that recruits a semantic
memory network during task-activated fMRI may be beneﬁcial for
studying healthy and degenerative aging processes. The FNDT can be
used to study activation attributable to memories of different ages and
can reveal the involvement of MTL structures during memory retrieval
of recent and remote material. Semantic processing paradigms have
also successfully demonstrated evidence of compensatory recruitment
and/or cognitive scaffolding in older compared to younger adults [59],
Fig. 5. From reference [63]. Effects of physical activity (PA) and risk for AD (APOE ε4 allele) on functional recruitment in cognitively intact older adults. 15 functional regions of interest are identiﬁed in the left panel with region numbers
(R#). Bar graphs represent mean percent MR signal intensity change for FamousNUnfamiliar name contrasts, for the main effects of PA (panel A) and Risk (panel B) and the interaction effect of PA×Risk (panel C). Post-hoc group differences
are indicated by brackets in panel C (pb .001). Error bars reﬂect the standard error of the mean. Figure reproduced with permission.
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Eighteen-month follow-up suggests that greater functional activation
during the FNDT in cortical and hippocampal brain regions is associated
with a reduced probability of cognitive decline [48]. This ﬁnding sug-
gests that cognitive scaffolding [107] may be a protective adaptation
to combat the declining functional integrity of neural resources that oc-
curswith both normal and pathological aging. There are also indications
from this work that fMRI activation during semantic processing tasks
may be advantageous over episodic memory paradigms for identifying
individuals who are at the greatest risk of cognitive decline [136]. The
most effective model for prediction of cognitive decline consisted of
fMRI activation during semanticmemory processing in cortical and hip-
pocampal regions and APOE allele status [48]. Reduced baseline hippo-
campal volume was also related to cognitive decline in a separate
model. Last, we reported that engagement in PA was associated with
greater task-induced fMRI semantic memory activation [63], which
may confer resistance to cognitive decline. However, these beneﬁts
may be limited to or at least enhanced in APOE ε4 carriers [147]. PA
was also associated with greater functional activity in the left caudate
in MCI patients [64], which may indicate preservation of caudate func-
tioning and possibly a reduced risk for conversion from MCI to AD.
These studies, combined with research from other groups, suggest
that the use of semantic processing tasks during fMRI may be a promis-
ing presymptomatic biomarker of future cognitive decline. Optimal use
of such a task may require integration with other relevant variables,
such as sMRI measures, APOE genotyping, assessment of habitual or
lifetime PA, or other biomarkers of AD [16].
4.2. Future longitudinal prediction
The prediction models derived from our longitudinal cohort [48,147]
were based on baseline and 18-month follow-up neuropsychological as-
sessments. This timeframemaybe somewhat brief for detecting clinically
signiﬁcant cognitive impairment; indeed, only two of our declining par-
ticipants met Petersen criteria for MCI [130]. We are now completing
neuropsychological follow-up for our original participants 5 years after
baseline. Analysis of these longer-term data will enable us to develop
more powerful models using baseline task-activated fMRI to predict cog-
nitive decline more accurately. The utilization of three time points will
also permit the development of predictionmodels for assessing multiple
trajectories of cognitive decline. For example, if a participant was cogni-
tively stable at 18-month follow-up but demonstrated decline after
5 years, is this pattern detectable at baseline? Likewise, if a participant
declined from baseline to 18 months but did not decline further at
5 years, can this pattern be predicted from baseline data? Additional fol-
low-up intervals may eventually permit further reﬁnement of a predic-
tion model of the risk for AD in cognitively intact, asymptomatic older
adults using fMRI activation during semantic memory processing tasks.
Other variables associated with the risk for developing AD can be
added to our sMRI, fMRI, and genotype models to further optimize pre-
diction. Thus, we can determine whether our identiﬁed predictors con-
tain independent or overlapping information pertaining to risk for
cognitive decline. Recently, we reported that self-report measures of PA
(but not self-reported participation in cognitively stimulating activities)
can enhance prediction of cognitive decline [147]. An upcoming project
involves the addition of blood plasma levels of homocysteine, folate,
and vitamin B12 to our prediction model. All three measures have been
implicated in risk for developing dementia [154,155].
4.3. Issues with the clinical adaptation of fMRI for the assessment of risk
We have proposed that fMRI in conjunction with other markers of
AD risk may be a valuable model for preclinical prediction of future
cognitive decline. However, several methodological issues associated
with fMRI may limit its clinical utility. First and foremost, between-
site standardization may be the largest hindrance preventing thedevelopment of normative data for widespread usage [156]. It has
been demonstrated that when an individual is scanned with the
same paradigm at multiple sites, there is substantial ﬂuctuation in
the spatial extent of the obtained BOLD signal [157]. Factors that con-
tribute to this variability include magnet manufacturer, the method
for sampling image information, the software used to construct the
image, the type of paradigm used, and perhaps most importantly,
magnet strength [156]. High ﬁeld strength (i.e. 3.0 T or greater) ap-
pears to yield the best between-site reproducibility [157].
Furthermore, the image processing time necessary for functional
data can contribute to additional expense. Given that the maximally ef-
fective prediction model would include other relevant (and perhaps
costly) variables such as APOE genotyping, blood serummeasurements,
and sMRI volumetrics, the total price tag of such a procedure may limit
accessibility. Patient motivation in the scanner may also be a relevant
factor that can inﬂuence the BOLD signal and/or behavioral performance
and reduce within-subject reliability. The presence of medical condi-
tions such as hypertension, diabetes, or hyperlipidemia (as well asmed-
ications associated with these conditions) may also inﬂuence activation
patterns and further complicate the establishment of usable norms
[156,158]. Dietary intake of common substances such as caffeine [159–
161] andnicotine [162–164], or thepresence of psychological comorbid-
ities such as depression [165,166], anxiety disorders [167–169], or psy-
chosis [170,171] also need to be accounted for when interpreting fMRI
data. Thus, while research studies have been successful in demonstrat-
ing fMRI's ability to assist in the prediction of cognitive decline, the ad-
aptation to clinical settings may require rigorous standardization.
4.4. Conclusion
Targeted intervention toward those at greatest risk is currently the
most promising strategy for anticipating and minimizing the burden
of AD. Great advances have beenmade in identifying lifestyle behaviors,
biological measurements, and neuroimaging biomarkers that are asso-
ciated with risk for dementia. Task-activated fMRI during semantic
memory processing may be a promising biomarker of future cognitive
decline. The FNDT can be completed even by individuals with MCI,
and task performance generally remains high [60]. Semantic memory
processing tasks, in conjunction with other risk factors or biomarkers,
may provide a sensitive and comprehensive estimate of an individual's
risk for late-life cognitive decline and dementia. Further longitudinal re-
search will produce additional preclinical prediction strategies that can
make the most effective use of emerging intervention strategies for AD.
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